Se connecter

Bibliographies thématiques / Interleukin-12 / Articles de revues

Pour voir les autres types de publications sur ce sujet consultez le lien suivant : Interleukin-12.

Articles de revues sur le sujet « Interleukin-12 »

Auteur : Grafiati

Publié le 4 juin 2021

Mis à jour le 25 juillet 2025

Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres

Choisissez une source :

Consultez les 50 meilleurs articles de revues pour votre recherche sur le sujet « Interleukin-12 ».

À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.

Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.

Parcourez les articles de revues sur diverses disciplines et organisez correctement votre bibliographie.

1

Leonard, Patricia, and Sanjiv Sur. "Interleukin-12." BioDrugs 17, no. 1 (2003): 1–7. http://dx.doi.org/10.2165/00063030-200317010-00001.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

2

&NA;. "Interleukin-12." Inpharma Weekly &NA;, no. 1124 (1998): 7. http://dx.doi.org/10.2165/00128413-199811240-00013.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

3

Trinchieri, Giorgio. "Interleukin-12." Clinical Immunotherapeutics 3, no. 4 (1995): 262–70. http://dx.doi.org/10.1007/bf03259278.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

4

Clinton, Steven K., Eduardo Canto, and Michael A. O'Donnell. "INTERLEUKIN-12." Urologic Clinics of North America 27, no. 1 (2000): 147–55. http://dx.doi.org/10.1016/s0094-0143(05)70242-1.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

5

Weiner, David. "Plasmid Interleukin 12." AIDS 14, no. 12 (2000): 1759–60. http://dx.doi.org/10.1097/00002030-200008180-00010.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

6

Leng, S. X., and J. A. Elias. "Interleukin-11 inhibits macrophage interleukin-12 production." Journal of Immunology 159, no. 5 (1997): 2161–68. http://dx.doi.org/10.4049/jimmunol.159.5.2161.

Texte intégral

Résumé :

Abstract IL-12 is a heterodimeric cytokine produced by phagocytic and other cells with important physiologic and pathologic properties. Regulated IL-12 production is crucial for the generation of protective Th1 responses to infectious agents. In contrast, IL-12 excess contributes to the pathogenesis of a variety of autoimmune and inflammatory disorders. To further understand the processes regulating IL-12 production, we determined whether IL-11 regulated monocyte/macrophage production of this cytokine moiety. IL-11 did not alter the IL-12 (p70) production of unstimulated THP-1 monocytic cells

Styles APA, Harvard, Vancouver, ISO, etc.

7

Fox, Robert J., and Abdolmohamad M. Rostami. "Anti???Interleukin-12 Antibody." BioDrugs 13, no. 4 (2000): 233–41. http://dx.doi.org/10.2165/00063030-200013040-00002.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

8

&NA;. "Interleukin-12 trial halted." Reactions Weekly &NA;, no. 556 (1995): 2. http://dx.doi.org/10.2165/00128415-199505560-00003.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

9

&NA;. "Interleukin-12 studies continue." Reactions Weekly &NA;, no. 558 (1995): 2. http://dx.doi.org/10.2165/00128415-199505580-00003.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

10

&NA;. "Interleukin-12 trial halted." Inpharma Weekly &NA;, no. 992 (1995): 21. http://dx.doi.org/10.2165/00128413-199509920-00047.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

11

&NA;. "Interleukin-12 studies continue." Inpharma Weekly &NA;, no. 994 (1995): 21. http://dx.doi.org/10.2165/00128413-199509940-00042.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

12

KATIYAR, S. "Interleukin-12 and photocarcinogenesis." Toxicology and Applied Pharmacology 224, no. 3 (2007): 220–27. http://dx.doi.org/10.1016/j.taap.2006.11.017.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

13

Maguire, H. C. "INTERLEUKIN 12 AS IMMUNOADJUVANT." Journal of Immunotherapy 16, no. 3 (1994): 240. http://dx.doi.org/10.1097/00002371-199410000-00032.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

14

de Rie, M. A. "Interleukin 12 and Psoriasis." Dermatology 199, no. 2 (1999): 101. http://dx.doi.org/10.1159/000018213.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

15

Trinchieri, Giorgio, and Franca Gerosa. "Immunoregulation by interleukin-12." Journal of Leukocyte Biology 59, no. 4 (1996): 505–11. http://dx.doi.org/10.1002/jlb.59.4.505.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

16

Ma, X., A. D'Andrea, M. Kubin, et al. "Production of interleukin-12." Research in Immunology 146, no. 7-8 (1995): 432–38. http://dx.doi.org/10.1016/0923-2494(96)83012-4.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

17

Crutcher, J. M., M. M. Stevenson, M. Sedegah, and S. L. Hoffman. "Interleukin-12 and malaria." Research in Immunology 146, no. 7-8 (1995): 552–59. http://dx.doi.org/10.1016/0923-2494(96)83031-8.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

18

Tsai, I. San, Chi-Cheng Tsai, Ya-Ping Ho, Kun-Yen Ho, Yi-Min Wu, and Chun-Cheng Hung. "Interleukin-12 and interleukin-16 in periodontal disease." Cytokine 31, no. 1 (2005): 34–40. http://dx.doi.org/10.1016/j.cyto.2005.02.007.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

19

BACON, CHRIS M., SARAH S. CHO, and JOHN J. O'SHEA. "Signal Transduction by Interleukin-12 and Interleukin-2." Annals of the New York Academy of Sciences 795, no. 1 Interleukin 1 (1996): 41–59. http://dx.doi.org/10.1111/j.1749-6632.1996.tb52654.x.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

20

Torti, Dorothea C., and Steven R. Feldman. "Interleukin-12, interleukin-23, and psoriasis: Current prospects." Journal of the American Academy of Dermatology 57, no. 6 (2007): 1059–68. http://dx.doi.org/10.1016/j.jaad.2007.07.016.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

21

Sánchez, E., S. Morales, L. Paco, et al. "Interleukin 12 (IL12B), interleukin 12 receptor (IL12RB1) and interleukin 23 (IL23A) gene polymorphism in systemic lupus erythematosus." Rheumatology 44, no. 9 (2005): 1136–39. http://dx.doi.org/10.1093/rheumatology/keh697.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

22

Orozco, Gisela, Miguel A. González-Gay, Laura Paco, et al. "Interleukin 12 (IL12B) and Interleukin 12 Receptor (IL12RB1) Gene Polymorphisms in Rheumatoid Arthritis." Human Immunology 66, no. 6 (2005): 710–14. http://dx.doi.org/10.1016/j.humimm.2005.02.004.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

23

Mattner, Frank, Susanne Fischer, Stefanie Guckes, et al. "The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer." European Journal of Immunology 23, no. 9 (1993): 2202–8. http://dx.doi.org/10.1002/eji.1830230923.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

24

Eman, Arif Rahman, Vitayani Muchtar Sri, Tabri Farida, et al. "EVALUATION OF INTERLEUKIN-12 AND INTERLEUKIN-4 LEVELS IN MULTIBACILLARY-TYPE LEPROSY PATIENT 12 MONTHS AFTER RIFAMPICIN OFLOXACIN MINOCYCLINE COMBINATION THERAPY." International Journal of Medical Reviews and Case Reports 2, no. 4 (2018): 161–65. https://doi.org/10.5455/IJMRCR.MULTIBACILLARY-TYPE-LEPROSY-INTERLEUKINS.

Texte intégral

Résumé :

Background: Leprosy is a chronic infectious disease caused by Mycobacterium leprae. In leprosy, cell-mediated immune responses are an important aspect of host resistance to mycobacterial infections and allegedly governed by anequilibrium between type 1 cytokines including Interleukin-12 (IL-12); with type 2 cytokines such as Interleukin-4 (IL-4). Currently, the World Health Organization (WHO) recommends 3 leprosy treatment regimens, one of them is Rifampicin Ofloxacin Minocycline (ROM). To date, studies on the effects of ROM on leprosy have been limited, none have specifically assessed the eff

Styles APA, Harvard, Vancouver, ISO, etc.

25

Lu, Zhiyu, Keye Xu, Xiaoying Wang, Yan Li, and Mingcai Li. "Interleukin 39: a new member of interleukin 12 family." Central European Journal of Immunology 45, no. 2 (2020): 214–17. http://dx.doi.org/10.5114/ceji.2020.97911.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

26

Rentzos, M., C. Nikolaou, E. Andreadou, et al. "Circulating interleukin-10 and interleukin-12 in Parkinson’s disease." Acta Neurologica Scandinavica 119, no. 5 (2009): 332–37. http://dx.doi.org/10.1111/j.1600-0404.2008.01103.x.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

27

Tahara, H., L. Zitvogel, W. J. Storkus, T. G. McKinney, P. D. Robbins, and M. T. Lotze. "CANCER GENE THERAPY USING INTERLEUKIN-12 (IL-12)." Journal of Immunotherapy 16, no. 3 (1994): 245. http://dx.doi.org/10.1097/00002371-199410000-00053.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

28

&NA;. "Interleukin-12 toxicity mystery solved." Reactions Weekly &NA;, no. 580 (1995): 2. http://dx.doi.org/10.2165/00128415-199505800-00002.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

29

&NA;. "Interleukin-12 toxicity mystery solved." Inpharma Weekly &NA;, no. 1016 (1995): 21. http://dx.doi.org/10.2165/00128413-199510160-00046.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

30

Romani, L., P. Puccetti, and F. Bistoni. "Interleukin-12 in infectious diseases." Clinical Microbiology Reviews 10, no. 4 (1997): 611–36. http://dx.doi.org/10.1128/cmr.10.4.611.

Texte intégral

Résumé :

Interleukin-12 (IL-12) is a potent immunoregulatory cytokine that is crucially involved in a wide range of infectious diseases. In several experimental models of bacterial, parasitic, viral, and fungal infection, endogenous IL-12 is required for early control of infection and for generation and perhaps maintenance of acquired protective immunity, directed by T helper type 1 (Th1) cells and mediated by phagocytes. Although the relative roles of IL-12 and gamma interferon in Th1-cell priming may be to a significant extent pathogen dependent, common to most infections is that IL-12 regulates the

Styles APA, Harvard, Vancouver, ISO, etc.

31

Romani, L., P. Puccetti, and F. Bistoni. "Interleukin-12 in infectious diseases." Clinical microbiology reviews 10, no. 4 (1997): 611–36. http://dx.doi.org/10.1128/cmr.10.4.611-636.1997.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

32

Bashyam, Hema. "Interleukin-12: A master regulator." Journal of Experimental Medicine 204, no. 5 (2007): 969. http://dx.doi.org/10.1084/jem.2045fta.

Texte intégral

Résumé :

Early resistance to pathogens requires a swift response from NK cells. In 1989, Giorgio Trinchieri identified an NK growth factor and activator, later called interleukin-12 (IL-12). This discovery helped reveal the regulatory link between innate and adaptive immunity.

Styles APA, Harvard, Vancouver, ISO, etc.

33

Adorini, Luciano. "Interleukin 12 and autoimmune diabetes." Nature Genetics 27, no. 2 (2001): 131–32. http://dx.doi.org/10.1038/84732.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

34

Bubeník, Jan. "Interleukin 12 in Cancer Treatment." Folia Biologica 57, no. 1 (2011): 1–2. http://dx.doi.org/10.14712/fb2011057010001.

Texte intégral

Résumé :

Interleukin 12 (IL-12) is made up of two disulphidelinked chains, p35 and p40. The cytokine is produced by monocytes, macrophages, myeloid dendritic cells and B cells. It stimulates development of NK cells and TH1 differentiation of CD4+ T cells, thus participating in the regulation of the immune response (for a review, see Klein and Hořejší, 1997; Grufman and Kärre, 2000; Jinushi and Tahara, 2009). Recently, the structurally similar but functionally different cytokine IL-23 displaying anti-tumour effects and related to the IL-12 family of cytokines was discovered (Engel and Neurath, 2010). In

Styles APA, Harvard, Vancouver, ISO, etc.

35

Sacks, G. P., D. Scott, H. Tivnann, T. Mire-Sluis, I. L. Sargent, and C. W. G. Redman. "Interleukin-12 and pre-eclampsia." Journal of Reproductive Immunology 34, no. 2 (1997): 155–58. http://dx.doi.org/10.1016/s0165-0378(97)00028-4.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

36

Bryan, Dani-Louise, Joanna S. Hawkes, and Robert A. Gibson. "Interleukin-12 in Human Milk." Pediatric Research 45, no. 6 (1999): 858–59. http://dx.doi.org/10.1203/00006450-199906000-00013.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

37

Sturmhoefel, K., K. Lee, M. O. Toole, H. M. Swiniarski, A. J. Dorner, and S. F. Wolf(xc*). "Interleukin 12 as vaccine adjuvant." Research in Immunology 149, no. 1 (1998): 37–39. http://dx.doi.org/10.1016/s0923-2494(98)80041-2.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

38

Rowe, PaulM. "Cautious optimism over interleukin-12." Lancet 345, no. 8962 (1995): 1432. http://dx.doi.org/10.1016/s0140-6736(95)92618-6.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

39

Trinchieri, Giorgio, Manthrasalam Rengaraju, Annalisa D'Andrea, et al. "Producer cells of interleukin-12." Immunology Today 14, no. 5 (1993): 237–38. http://dx.doi.org/10.1016/0167-5699(93)90173-i.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

40

MA, XIAOJING, MIGUEL ASTE-AMEZAGA, and GIORGIO TRINCHIERI. "Regulation of Interleukin-12 Production." Annals of the New York Academy of Sciences 795, no. 1 Interleukin 1 (1996): 13–25. http://dx.doi.org/10.1111/j.1749-6632.1996.tb52651.x.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

41

BLISS, JUDY, RICHARD MAYLOR, KEYA STOKES, KRISTIN S. MURRAY, MARA A. KETCHUM, and STANLEY F. WOLF. "Interleukin-12 as Vaccine Adjuvant." Annals of the New York Academy of Sciences 795, no. 1 Interleukin 1 (1996): 26–35. http://dx.doi.org/10.1111/j.1749-6632.1996.tb52652.x.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

42

Podlaski, Frank J., Venkata B. Nanduri, Jeffrey D. Hulmes, et al. "Molecular characterization of interleukin 12." Archives of Biochemistry and Biophysics 294, no. 1 (1992): 230–37. http://dx.doi.org/10.1016/0003-9861(92)90162-p.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

43

Trinchieri, Giorgio, Manthrasalam Rengaraju, Annalisa D'Andrea, et al. "Producer cells of interleukin 12." Parasitology Today 9, no. 3 (1993): 97. http://dx.doi.org/10.1016/0169-4758(93)90215-2.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

44

Brunda, Michael J., and Maurice K. Gately. "Antitumor Activity of Interleukin-12." Clinical Immunology and Immunopathology 71, no. 3 (1994): 253–55. http://dx.doi.org/10.1006/clin.1994.1081.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

45

Karp, Christopher L. "Interleukin-12: Amiss in MS." Annals of Neurology 45, no. 6 (1999): 689–92. http://dx.doi.org/10.1002/1531-8249(199906)45:6<689::aid-ana1>3.0.co;2-m.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

46

Gately, Maurice K., Louis M. Renzetti, Jeanne Magram, et al. "THE INTERLEUKIN-12/INTERLEUKIN-12-RECEPTOR SYSTEM: Role in Normal and Pathologic Immune Responses." Annual Review of Immunology 16, no. 1 (1998): 495–521. http://dx.doi.org/10.1146/annurev.immunol.16.1.495.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

47

Wang, Xin, Victoria L. Wilkinson, Frank J. Podlaski, et al. "Characterization of mouse interleukin-12 p40 homodimer binding to the interleukin-12 receptor subunits." European Journal of Immunology 29, no. 6 (1999): 2007–13. http://dx.doi.org/10.1002/(sici)1521-4141(199906)29:06<2007::aid-immu2007>3.0.co;2-0.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

48

Yücel, Özlem Özer, Ezel Berker, Semra Gariboğlu та Harika Otlu. "Interleukin-11, interleukin-1β, interleukin-12 and the pathogenesis of inflammatory periodontal diseases". Journal of Clinical Periodontology 35, № 5 (2008): 365–70. http://dx.doi.org/10.1111/j.1600-051x.2008.01212.x.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

49

GATELY, MAURICE K., DAISY M. CARVAJAL, SUZANNE E. CONNAUGHTON, et al. "Interleukin-12 Antagonist Activity of Mouse Interleukin-12 p40 Homodimer in Vitro and in Vivo." Annals of the New York Academy of Sciences 795, no. 1 Interleukin 1 (1996): 1–12. http://dx.doi.org/10.1111/j.1749-6632.1996.tb52650.x.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

50

Robinson, Cory M., and Gerard J. Nau. "Interleukin‐12 and Interleukin‐27 Regulate Macrophage Control ofMycobacterium tuberculosis." Journal of Infectious Diseases 198, no. 3 (2008): 359–66. http://dx.doi.org/10.1086/589774.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Nous offrons des réductions sur tous les plans premium pour les auteurs dont les œuvres sont incluses dans des sélections littéraires thématiques. Contactez-nous pour obtenir un code promo unique!